FNCH - Finch Therapeutics GAAP EPS of -$1.33 misses by $1.24 revenue of $0.11M May, 10 2023 01:37 PM Finch Therapeutics Group Inc. 2023-05-10 13:37:04 ET Finch Therapeutics press release ( NASDAQ: FNCH ): Q1 GAAP EPS of -$1.33 misses by $1.24 . Revenue of $0.11M (-68.6% Y/Y). For further details see: Finch Therapeutics GAAP EPS of -$1.33 misses by $1.24, revenue of $0.11M